Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Junpei Hamaguchi"'
Autor:
Masaya Matsuda, Kana Doi, Tatsuya Tsutsumi, Miki Inaba, Junpei Hamaguchi, Tetsuya Terada, Ryo Kawata, Kazuyuki Kitatani, Takeshi Nabe
Publikováno v:
Journal of Pharmacological Sciences, Vol 141, Iss 4, Pp 139-145 (2019)
Type 1 regulatory T (Tr1) cells are CD4+ T cells that produce a large amount of IL-10, an anti-inflammatory cytokine. However, it has not been fully elucidated whether Tr1 cells suppress allergic asthma. In this study, the effects of adoptive transfe
Externí odkaz:
https://doaj.org/article/46df5781e0b94efc80ee5ef7aca125c1
Autor:
Yusuke Kikuoka, Masaya Matsuda, Kennosuke Hashimoto, Takeshi Nabe, Harumi Sakae, Kazuyuki Kitatani, Junpei Hamaguchi, Ryo Kawata, Miki Inaba, Hayato Shimora, Yuko Inaka, Naoki Takemoto, Tetsuya Terada
Publikováno v:
Inflammation Research. 70:581-589
At least 3 years of sublingual immunotherapy (SLIT) is required to achieve long-term clinical tolerance for allergens. However, immunological changes with more than 3 years of SLIT have not yet been elucidated in detail. The present study investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::765aabddb9eb8f9beba4c29729f01c30
https://doi.org/10.1007/s00011-021-01460-3
https://doi.org/10.1007/s00011-021-01460-3
Autor:
Junpei Hamaguchi, Ryo Kawata, Masaya Matsuda, Kana Doi, Takeshi Nabe, Miki Inaba, Kazuyuki Kitatani, Tatsuya Tsutsumi, Tetsuya Terada
Publikováno v:
Journal of Pharmacological Sciences, Vol 141, Iss 4, Pp 139-145 (2019)
Type 1 regulatory T (Tr1) cells are CD4+ T cells that produce a large amount of IL-10, an anti-inflammatory cytokine. However, it has not been fully elucidated whether Tr1 cells suppress allergic asthma. In this study, the effects of adoptive transfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78da9025a72483df2c6263c014f33494
https://doi.org/10.1016/j.jphs.2019.10.004
https://doi.org/10.1016/j.jphs.2019.10.004
Autor:
Nau Tsujimoto, Shuji Omura, Yusuke Ayani, Yuki Tabuchi, Tomoki Ishida, Tetsuya Terada, Keiki Noro, Kana Doi, Yuki Morie, Takahiro Ichihara, Yuko Inaka, Yusuke Kikuoka, Takeshi Nabe, Masaya Matsuda, Junpei Hamaguchi, Ryo Kawata, Takuya Yoshida, Manabu Suzuki, Takaki Inui, Hiromu Takahashi
Publikováno v:
Immunotherapy. 11:473-482
Aim: The aim of this study was to clarify whether there are more regulatory T (Treg) and regulatory B (Breg) cells, and higher levels of IL-10-related transcription factors in subcutaneous immunotherapy (SCIT)-treated pollinosis patients than in non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f99348b190dbe357555226a8901b97
https://doi.org/10.2217/imt-2018-0170
https://doi.org/10.2217/imt-2018-0170
Autor:
Tetsuya, Terada, Masaya, Matsuda, Miki, Inaba, Junpei, Hamaguchi, Naoki, Takemoto, Yusuke, Kikuoka, Yuko, Inaka, Harumi, Sakae, Kennosuke, Hashimoto, Hayato, Shimora, Kazuyuki, Kitatani, Ryo, Kawata, Takeshi, Nabe
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 70(5)
At least 3 years of sublingual immunotherapy (SLIT) is required to achieve long-term clinical tolerance for allergens. However, immunological changes with more than 3 years of SLIT have not yet been elucidated in detail. The present study investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6068bc66f0a5a612979c4fffb26a9671
https://pubmed.ncbi.nlm.nih.gov/33837438
https://pubmed.ncbi.nlm.nih.gov/33837438
Autor:
Junpei Hamaguchi, Masaya Matsuda, Yuki Morie, Tatsuya Tsutsumi, Takeshi Nabe, Miki Inaba, Hirotaka Oze, Kana Doi
Publikováno v:
International Immunopharmacology. 61:297-305
Introduction The mechanisms of allergen immunotherapy are not fully elucidated. Here, we sought to develop a murine model to demonstrate the effectiveness of subcutaneous immunotherapy (SCIT) for allergic responses. As excessive antigen dosages may i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79c32813b6c0302b4043ed048285cfe1
https://doi.org/10.1016/j.intimp.2018.06.014
https://doi.org/10.1016/j.intimp.2018.06.014
Autor:
Junpei Hamaguchi, Masaya Matsuda, Hiromu Takahashi, Nau Tsujimoto, Takeshi Nabe, Tetsuya Terada, Kana Doi, Tomoki Ishida, Yuki Morie, Ryo Kawata
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63a447d7a93c0c3abe43037b08e00fbe
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-4-6
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-4-6
Autor:
Masaya, Matsuda, Yuki, Morie, Hirotaka, Oze, Kana, Doi, Tatsuya, Tsutsumi, Junpei, Hamaguchi, Miki, Inaba, Takeshi, Nabe
Publikováno v:
International immunopharmacology. 61
The mechanisms of allergen immunotherapy are not fully elucidated. Here, we sought to develop a murine model to demonstrate the effectiveness of subcutaneous immunotherapy (SCIT) for allergic responses. As excessive antigen dosages may induce immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85f98413cd4f6c732bf339eb4a7f7e09
https://pubmed.ncbi.nlm.nih.gov/29909233
https://pubmed.ncbi.nlm.nih.gov/29909233